We determined both intestinal mucosa and PBMC IL-23R in IBD patients and observed that intestinal mucosa lnc-ITSN1-2 was positively correlated to IL-23R in CD (Figure 4H) and UC patients (Figure 4P). Here, IL23R is linked to inflammatory bowel disease.